Kubota Pharmaceutical Holdings Co., Ltd. (4596.T)
JPY 57.0
(0.0%)
JPY 57.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -1.48 Billion JPY | 26.11% |
| 2022 | -2.01 Billion JPY | 22.95% |
| 2021 | -2.61 Billion JPY | -7.34% |
| 2020 | -2.43 Billion JPY | 20.49% |
| 2019 | -3.06 Billion JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -342.74 Million JPY | 25.9% |
| 2024 Q2 | -326.19 Million JPY | 4.83% |
| 2023 Q3 | -282.39 Million JPY | 5.98% |
| 2023 FY | -1.48 Billion JPY | 26.11% |
| 2023 Q2 | -300.35 Million JPY | 32.4% |
| 2023 Q1 | -444.33 Million JPY | -32.62% |
| 2023 Q4 | -462.51 Million JPY | -63.78% |
| 2022 Q3 | -484.03 Million JPY | 0.0% |
| 2022 FY | -2.01 Billion JPY | 22.95% |
| 2022 Q4 | -335.03 Million JPY | 30.78% |
| 2021 FY | -2.61 Billion JPY | -7.34% |
| 2020 FY | -2.43 Billion JPY | 20.49% |
| 2019 FY | -3.06 Billion JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 384 Million JPY | 487.917% |
| PRISM BioLab Co.,LTD | -526.91 Million JPY | -182.703% |
| GNI Group Ltd. | 8.09 Billion JPY | 118.403% |
| Linical Co., Ltd. | 338.26 Million JPY | 540.364% |
| Trans Genic Inc. | 4.08 Million JPY | 36565.165% |
| MEDINET Co., Ltd. | -1.43 Billion JPY | -3.592% |
| Soiken Holdings Inc. | -662.2 Million JPY | -124.946% |
| Cytori Cell Research Institute, Inc. | 138.15 Million JPY | 1178.211% |
| AnGes, Inc. | -7.43 Billion JPY | 79.972% |
| OncoTherapy Science, Inc. | -1.28 Billion JPY | -15.64% |
| Nxera Pharma Co., Ltd. | -7.19 Billion JPY | 79.291% |
| Immuno-Biological Laboratories Co., Ltd. | 186.69 Million JPY | 897.884% |
| NanoCarrier Co., Ltd. | -780 Million JPY | -90.974% |
| Carna Biosciences, Inc. | -1.15 Billion JPY | -29.205% |
| CanBas Co., Ltd. | -1.2 Billion JPY | -23.209% |
| D. Western Therapeutics Institute, Inc. | -812.41 Million JPY | -83.356% |
| RaQualia Pharma Inc. | -323.66 Million JPY | -360.234% |
| Chiome Bioscience Inc. | -1.22 Billion JPY | -22.097% |
| Kidswell Bio Corporation | -1.42 Billion JPY | -4.748% |
| PeptiDream Inc. | 3.03 Billion JPY | 149.067% |
| Oncolys BioPharma Inc. | -1.93 Billion JPY | 23.157% |
| Ribomic Inc. | -1.02 Billion JPY | -45.435% |
| SanBio Company Limited | -2.64 Billion JPY | 43.661% |
| Healios K.K. | -3.82 Billion JPY | 61.036% |
| BrightPath Biotherapeutics Co., Ltd. | -1.16 Billion JPY | -27.525% |
| Delta-Fly Pharma, Inc. | -1.42 Billion JPY | -4.212% |
| StemRIM | -2.02 Billion JPY | 26.33% |
| CellSource Co., Ltd. | 923.14 Million JPY | 261.362% |
| FunPep Company Limited | -933.41 Million JPY | -59.586% |
| Kringle Pharma, Inc. | -854.15 Million JPY | -74.396% |
| Stella Pharma Corporation | -763.74 Million JPY | -95.038% |
| TMS Co., Ltd. | -960.04 Million JPY | -55.16% |
| Noile-Immune Biotech Inc. | -1.13 Billion JPY | -31.822% |
| Cuorips Inc. | -632.18 Million JPY | -135.628% |
| K Pharma,Inc. | 260.33 Million JPY | 672.198% |
| Takara Bio Inc. | 1.48 Billion JPY | 200.649% |
| ReproCELL Incorporated | -31.41 Million JPY | -4641.69% |
| PhoenixBio Co., Ltd. | 26.37 Million JPY | 5747.138% |
| StemCell Institute Inc. | 310.98 Million JPY | 579.001% |
| Japan Tissue Engineering Co., Ltd. | 143.16 Million JPY | 1140.45% |
| CellSeed Inc. | -846.53 Million JPY | -75.965% |